Words for clinical notes
Search 5,131 terms by clinical wording, everyday description, or note example.
| Word | Plain-English search cue | Original note example | SOAP section | Writing task |
|---|---|---|---|---|
absorption lag time | delay between dosing and the start of measurable absorption in a model | The model includes an absorption lag time before concentrations begin to rise. | Assessment | Drug concentrations, exposure and assay interpretation |
absorption rate constant | parameter describing the rate of absorption in a specified model | The fitted absorption rate constant was reported with its units and model assumptions. | Assessment | Drug concentrations, exposure and assay interpretation |
accumulation ratio | measure of exposure after repeated dosing relative to a stated earlier exposure | The reported accumulation ratio compares the same exposure metric across intervals. | Assessment | Drug concentrations, exposure and assay interpretation |
acetaminophen | analgesic measured in timed exposure assessments when clinically indicated | The acetaminophen concentration is recorded alongside the reported ingestion time. | Objective | Drug levels - named analytes and exposure reports |
active metabolite exposure | exposure to a metabolite that also has pharmacologic activity | Active metabolite exposure was reviewed separately from the parent concentration. | Assessment | Medication response, exposure and reconciliation |
analytical interference | substance or sample property alters the reported measurement | Possible analytical interference was discussed with the laboratory before interpreting the value. | Assessment | Drug concentrations, exposure and assay interpretation |
apparent oral clearance | apparent clearance after oral dosing, expressed relative to bioavailability | The model reports apparent oral clearance because absolute bioavailability was not measured. | Assessment | Drug concentrations, exposure and assay interpretation |
assay cross-reactivity | measurement response to substances other than the intended analyte | The laboratory was asked whether assay cross-reactivity might affect the immunoassay result. | Assessment | Drug concentrations, exposure and assay interpretation |
assay imprecision | random variation on repeated measurement of the same material | The difference between near-identical repeat results may reflect assay imprecision. | Assessment | Drug concentrations, exposure and assay interpretation |
AUC extrapolated to infinity | total single-dose exposure estimated beyond the last sample using terminal decline | The AUC extrapolated to infinity includes a separately reported extrapolated portion. | Assessment | Drug concentrations, exposure and assay interpretation |
below quantification | present or reported below a reliable numeric reporting limit | The analyte was reported as below quantification without an exact concentration. | Objective | Drug levels - analyte, specimen and reporting |
calibration shift | systematic change in results related to measurement calibration | The laboratory reviewed for a calibration shift after the analyzer change. | Assessment | Drug concentrations, exposure and assay interpretation |
continuous infusion rate | amount delivered per unit time throughout an ongoing infusion | Continuous infusion rate was recorded with concentration and pump units. | Objective | Vascular access and infusion observations |
dialysate | fluid used for solute exchange during dialysis | The dialysate potassium concentration is listed on the treatment sheet. | Objective | Kidney function, urine sediment and dialysis observations |
dose proportionality | whether exposure changes in proportion to the dose change | The reviewer discusses dose proportionality before comparing the two concentrations. | Assessment | Medication exposure, response and adverse-effect reasoning |
effective half-life | half-life used to describe accumulation or decline for the specified situation | The interpretation specifies how the effective half-life was estimated. | Assessment | Drug concentrations, exposure and assay interpretation |
elimination | removal of drug by metabolism and excretion | The falling concentrations are being reviewed alongside renal elimination. | Assessment | Drug levels - exposure and pharmacokinetics |
enterohepatic recycling | drug or metabolite returns to circulation after biliary excretion and intestinal reabsorption | Enterohepatic recycling was discussed when interpreting the multiphasic concentration curve. | Assessment | Medication response, exposure and reconciliation |
erythrocyte partitioning | distribution of drug into red blood cells | The choice of whole blood as the specimen reflects erythrocyte partitioning. | Assessment | Drug concentrations, exposure and assay interpretation |
extrapolated AUC fraction | part of the total estimated exposure derived from extrapolation | The extrapolated AUC fraction was reviewed because the late sampling period was short. | Assessment | Drug concentrations, exposure and assay interpretation |
fibrinogen | clotting protein converted into fibrin | The fibrinogen concentration was rechecked on the repeat sample. | Objective | Hematology, coagulation and transfusion observations |
first-pass extraction | presystemic removal before an absorbed dose reaches systemic circulation | The route change prompted review of possible first-pass extraction. | Assessment | Drug concentrations, exposure and assay interpretation |
globulin | group of circulating proteins other than albumin | The report lists a calculated globulin concentration. | Objective | Hepatobiliary, pancreatic and nutrition findings |
hepatic extraction ratio | fraction of drug removed from blood during one passage through the liver | The pharmacology note distinguishes the hepatic extraction ratio from total clearance. | Assessment | Drug concentrations, exposure and assay interpretation |
| test that uses antibody recognition | The outside concentration was measured by immunoassay. | Objective | Drug levels - analyte, specimen and reporting |